Publications by authors named "Charlie Iaconangelo"

Claim this Profile
E
Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trials.
Charlie J Iaconangelo, Daniel Serrano, Aubrey Manack Adams, Joel M Trugman, Richard B Lipton

Headache· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease.
Alaa Hamed, Pronabesh DasMahapatra, Nicole Lyn, Chad Gwaltney, Charlie Iaconangelo

Mol Genet Metab Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura.
Richard B Lipton, Sagar Munjal, Stewart J Tepper, Charlie Iaconangelo, Daniel Serrano

J Pain Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial.
Richard B Lipton, Sagar Munjal, David W Dodick, Stewart J Tepper, Daniel Serrano, Charlie Iaconangelo

J Pain Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis